🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Armeen Mahvash

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0003-0416-4566

Also affiliated with Scripps MD Anderson Cancer Center

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.7Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation

Scientific Data(2023)10.1038/s41597-023-01928-3

Top 12%

1.7DataRank

Top 12%47 citations

Ali Morshid, Ahmed Khalaf, Mohab M. Elmohr, John D. Hazle, David Fuentes +12 more

Papers

Driven by 14 papers — median percentile 88. Top paper: “Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation”.

Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation

Scientific Data(2023)10.1038/s41597-023-01928-3

Top 12%

1.7DataRank

Top 12%47 citations

Ali Morshid, Ahmed Khalaf, Mohab M. Elmohr, John D. Hazle, David Fuentes +12 more

Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors

JAMA Oncology(2022)10.1001/jamaoncol.2022.0212

N/A

1.1DataRank · unranked

40 citations

Suyu Liu, Arvind Dasari, David R. Fogelman, Priya Bhosale, Armeen Mahvash +21 more

Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0331

N/A

0.648DataRank · unranked

74 citations

Suyu Liu, Michael J. Overman, Anneleis F. Willett, Mark Knafl, Szu-Chin Fu +29 more

Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite

Surgical Oncology(2021)10.1016/j.suronc.2021.101648

N/A

0.506DataRank · unranked

13 citations

Bruno C. Odisio, Jenilette D. Velasco, Elizabeth Ninan, Steven Y. Huang, Armeen Mahvash +5 more

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients

Oncotarget(2022)10.18632/oncotarget.28322

N/A

0.434DataRank · unranked

17 citations

Dan G. Duda, Muhammad O. Awiwi, Sunyoung S. Lee, Lina Altameemi, Lianchun Xiao +13 more

Bioprosthetic valve monitoring in patients with carcinoid heart disease

Frontiers in Cardiovascular Medicine(2023)10.3389/fcvm.2022.1072890

N/A

0.365DataRank · unranked

5 citations

Saamir Hassan, Anita Deswal, Joerg Herrmann, Juhee Song, Dominique Monlezun +17 more

Quantitative evaluation of 90Y‐PET/CT and 90Y‐SPECT/CT‐based dosimetry following Yttrium‐90 radioembolization

Medical Physics(2024)10.1002/mp.17175

N/A

0DataRank · unranked

6 citations

Éric Henry, Benjamín López, Armeen Mahvash, S. Cheenu Kappadath

Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study

Oral Oncology(2024)10.1016/j.oraloncology.2024.106747

N/A

0DataRank · unranked

2 citations

S. Liu, Priya Bhosale, Mehmet Altan, W. Darbonne, Katja Schulze +14 more

A comparison of methods for in vivo activity and absorbed dose quantification with PET/CT following yttrium‐90 radioembolization

Medical Physics(2024)10.1002/mp.17174

N/A

0DataRank · unranked

1 citations

Armeen Mahvash, Benjamín López, S. Cheenu Kappadath, Éric Henry

Involution of Hepatocellular Neoplasm after Embolization of a Portosystemic Vascular Shunt in an Adult with Abernethy Type II Malformation

Journal of Vascular and Interventional Radiology(2021)10.1016/j.jvir.2021.05.026

N/A

0DataRank · unranked

1 citations

Yujiro Nishioka, Jenilette D. Velasco, Armeen Mahvash, Reza J. Mehran, Lan S. Wang +4 more

Predicting the net administered activity in 90Y‐radioembolization patients from post‐procedure 90Y‐SPECT/CT

Medical Physics(2023)10.1002/mp.16540

N/A

0DataRank · unranked

5 citations

Benjamín López, Armeen Mahvash, M.A. Thomas, S. Cheenu Kappadath, Éric Henry

Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features

The Oncologist(2023)10.1093/oncolo/oyad329

N/A

0DataRank · unranked

1 citations

Russell G. Witt, Khaled M. Elsayes, Ali Baiomy, Lianchun Xiao, Sarah Palmquist +14 more

Data from Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

(2023)10.1158/2159-8290.c.6549433.v1

N/A

0DataRank · unranked

0 citations

Suyu Liu, Michael J. Overman, Anneleis F. Willett, Mark Knafl, Szu‐Chin Fu +29 more

Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab

Cancer Biomarkers(2024)10.3233/cbm-230431

N/A

0DataRank · unranked

12 citations

Sunyoung S. Lee, Tarık Demir, Shadi Chamseddine, Zishuo Ian Hu, Lianchun Xiao +17 more